Picture of CureVac NV logo

5CV CureVac NV Share Price

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapSucker Stock

Momentum

Relative Strength (%)
1m-13.83%
3m-30.16%
6m-64.87%
1yr-59.13%
Volume Change (%)
10d/3m-16.67%
Price vs... (%)
52w High-74.38%
50d MA-9.86%
200d MA-51.01%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-44.47%
Return on Equity-49.26%
Operating Margin-717.59%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of CureVac NV EPS forecast chart

Profile Summary

CureVac AG is a clinical-stage biopharmaceutical company, The Company strives to create transformative medicines to protect and improve people’s lives. Fueled by proprietary RNA technology platform combined with two decades of science and manufacturing, The Company is dedicated to creating novel treatments that enable the body to make its own prophylactic and therapeutic drugs.

Directors

Last Annual
December 31st, 2022
Last Interim
September 30th, 2023
Incorporated
April 7th, 2020
Public Since
August 14th, 2020
No. of Employees
1,049
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
de flag iconFrankfurt Stock Exchange
Shares in Issue
223,923,708

5CV Share Price Performance

Upcoming Events for 5CV

Q4 2023 CureVac NV Earnings Release

Q1 2024 CureVac NV Earnings Release

CureVac NV Annual Shareholders Meeting

Q2 2024 CureVac NV Earnings Release

Similar to 5CV

Picture of 4Sc AG logo

4Sc AG

de flag iconFrankfurt Stock Exchange

Picture of Diagonal Bio AB logo

Diagonal Bio AB

de flag iconFrankfurt Stock Exchange

Picture of Medpace Holdings logo

Medpace Holdings

de flag iconFrankfurt Stock Exchange

Picture of PAION AG logo

PAION AG

de flag iconFrankfurt Stock Exchange

Picture of Qiagen NV logo

Qiagen NV

de flag iconFrankfurt Stock Exchange

FAQ